Literature DB >> 30466166

Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.

Rohan R Joshi1,2, Qasim Husain1,2, Benjamin R Roman, Jennifer Cracchiolo3, Yao Yu4, Jillian Tsai4, Julie Kang4, Sean McBride4, Nancy Y Lee4, Luc Morris3, Ian Ganly3, Viviane Tabar5, Marc A Cohen3.   

Abstract

BACKGROUND: Esthesioneuroblastoma (ENB) is a rare neuroendocrine tumor. The purpose of this study was to compare the Kadish, tumor-node-metastasis (TNM), and Dulguerov's modified TNM staging in order to determine the impact of the stage on primary surgical treatment selection, margin status, and survival.
METHODS: The National Cancer Database (NCDB) was used to identify patients diagnosed with ENB between 2004 to 2015. Patients were excluded based on the ability to properly stage their disease as well as the availability of treatment data.
RESULTS: Eight-hundred eighty-three patients had sufficient data for analysis. On multivariate analysis, age and government insurance were associated with primary surgical treatment, whereas tumor stage, gender, race, hospital type and volume, and comorbidity score were not. Age, charlson-deyo comorbidity (CDCC) score, hospital volume, and nodal status were found to be predictors of survival. Multivariate-analysis controlling for stage failed to demonstrate clear survival differences between staging in both TNM and Kadish systems. T-stage and the presence of regional nodal metastasis were associated with an increased risk of positive margins on multivariate analysis.
CONCLUSION: Although primary surgical management and positive margins can be predicted by certain patient and tumor factors, clinical staging systems for ENB poorly predict prognosis over a 10-year horizon.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  esthesioneuroblastoma; national cancer database; sinonasal malignancies; sinonasal neoplasm

Mesh:

Year:  2018        PMID: 30466166      PMCID: PMC6352736          DOI: 10.1002/jso.25293

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  37 in total

Review 1.  Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience.

Authors:  Rod J Oskouian; John A Jane; Aaron S Dumont; Jonas M Sheehan; Jeffrey J Laurent; Paul A Levine
Journal:  Neurosurg Focus       Date:  2002-05-15       Impact factor: 4.047

2.  Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.

Authors:  Daniel Jethanamest; Luc G Morris; Andrew G Sikora; David I Kutler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-03

3.  Olfactory neuroblastoma. A clinical analysis of 17 cases.

Authors:  S Kadish; M Goodman; C C Wang
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

Review 4.  Esthesioneuroblastoma: a meta-analysis and review.

Authors:  P Dulguerov; A S Allal; T C Calcaterra
Journal:  Lancet Oncol       Date:  2001-11       Impact factor: 41.316

5.  Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.

Authors:  Eduardo M Diaz; Richard H Johnigan; Colin Pero; Adel K El-Naggar; Dianna B Roberts; James L Barker; Franco DeMonte
Journal:  Head Neck       Date:  2005-02       Impact factor: 3.147

6.  Esthesioneuroblastoma: the Johns Hopkins experience.

Authors:  V A Resto; D W Eisele; A Forastiere; M Zahurak; D J Lee; W H Westra
Journal:  Head Neck       Date:  2000-09       Impact factor: 3.147

7.  Esthesioneuroblastoma: continued follow-up of a single institution's experience.

Authors:  Andrew H Loy; James F Reibel; Paul W Read; Christopher Y Thomas; Steven A Newman; John A Jane; Paul A Levine
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-02

8.  Esthesioneuroblastoma: the UCLA experience 1970-1990.

Authors:  P Dulguerov; T Calcaterra
Journal:  Laryngoscope       Date:  1992-08       Impact factor: 3.325

9.  Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.

Authors:  Alan T Monroe; Russell W Hinerman; Robert J Amdur; Christopher G Morris; William M Mendenhall
Journal:  Head Neck       Date:  2003-07       Impact factor: 3.147

10.  Combined modality therapy of esthesioneuroblastoma.

Authors:  J Nicolas McLean; Sunjay R Nunley; Carmen Klass; Charles Moore; Susan Müller; Peter A S Johnstone
Journal:  Otolaryngol Head Neck Surg       Date:  2007-06       Impact factor: 3.497

View more
  11 in total

1.  [68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.

Authors:  Michelle Roytman; Andrew B Tassler; Ashutosh Kacker; Theodore H Schwartz; Georgiana A Dobri; Sara B Strauss; Alyssa M Capalbo; Rajiv S Magge; Marissa Barbaro; Eaton Lin; Joseph R Osborne
Journal:  J Neurosurg Case Lessons       Date:  2021-01-11

2.  Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Authors:  Matt Lechner; Yoko Takahashi; Mario Turri-Zanoni; Jacklyn Liu; Nicholas Counsell; Mario Hermsen; Raman Preet Kaur; Tianna Zhao; Murugappan Ramanathan; Volker H Schartinger; Oscar Emanuel; Sam Helman; Jordan Varghese; Jozsef Dudas; Herbert Riechelmann; Susanne Sprung; Johannes Haybaeck; David Howard; Nils Wolfgang Engel; Sarah Stewart; Laura Brooks; Jessica C Pickles; Thomas S Jacques; Tim R Fenton; Luke Williams; Francis M Vaz; Paul O'Flynn; Paul Stimpson; Simon Wang; S Alam Hannan; Samit Unadkat; Jonathan Hughes; Raghav Dwivedi; Cillian T Forde; Premjit Randhawa; Simon Gane; Jonathan Joseph; Peter J Andrews; Gary Royle; Alessandro Franchi; Roberta Maragliano; Simonetta Battocchio; Helen Bewicke-Copley; Christodoulos Pipinikas; Amy Webster; Chrissie Thirlwell; Debbie Ho; Andrew Teschendorff; Tianyu Zhu; Christopher D Steele; Nischalan Pillay; Bart Vanhaesebroeck; Ahmed Mohyeldin; Juan Fernandez-Miranda; Ki Wan Park; Quynh-Thu Le; Robert B West; Rami Saade; R Peter Manes; Sacit Bulent Omay; Eugenia M Vining; Benjamin L Judson; Wendell G Yarbrough; Maddalena Sansovini; Nicolini Silvia; Ilaria Grassi; Alberto Bongiovanni; David Capper; Ulrich Schüller; Selvam Thavaraj; Ann Sandison; Pavol Surda; Claire Hopkins; Marco Ferrari; Davide Mattavelli; Vittorio Rampinelli; Fabio Facchetti; Piero Nicolai; Paolo Bossi; Oswaldo A Henriquez; Kelly Magliocca; C Arturo Solares; Sarah K Wise; Jose L Llorente; Zara M Patel; Jayakar V Nayak; Peter H Hwang; Peter D Lacy; Robbie Woods; James P O'Neill; Amrita Jay; Dawn Carnell; Martin D Forster; Masaru Ishii; Nyall R London; Diana M Bell; Gary L Gallia; Paolo Castelnuovo; Stefano Severi; Valerie J Lund; Ehab Y Hanna
Journal:  Eur J Cancer       Date:  2021-12-31       Impact factor: 10.002

3.  Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma.

Authors:  Jingyi Yang; Xiaole Song; Yuting Lai; Weidong Zhao; Jiaying Zhou; Quan Liu; Wanpeng Li; Huankang Zhang; Huan Wang; Peng Shi; Hongmeng Yu; Xicai Sun; Dehui Wang
Journal:  EClinicalMedicine       Date:  2020-11-30

4.  Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.

Authors:  Ruichen Li; Shu Tian; Yi Zhu; Li Yan; Wenjia Zhu; Huatao Quan; Shengzi Wang
Journal:  Radiat Oncol       Date:  2019-06-13       Impact factor: 3.481

5.  Mixed olfactory neuroblastoma and neuroendocrine carcinoma: An unusual case report and literature review.

Authors:  Wilson P Lao; Jordan M Thompson; Lauran Evans; Yohanan Kim; Laura Denham; Steve C Lee
Journal:  Surg Neurol Int       Date:  2020-05-09

6.  Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.

Authors:  Meng Sun; Kai Wang; Yuan Qu; Jianghu Zhang; Shiping Zhang; Xuesong Chen; Jingbo Wang; Runye Wu; Ye Zhang; Junlin Yi; Jianping Xiao; Guozhen Xu; Xiaodong Huang; Jingwei Luo
Journal:  Radiat Oncol       Date:  2020-09-18       Impact factor: 3.481

7.  Short-Term Morbidity and Predictors of Adverse Events Following Esthesioneuroblastoma Surgery.

Authors:  Khodayar Goshtasbi; Jack L Birkenbeuel; Mehdi Abouzari; Brandon M Lehrich; Tyler M Yasaka; Arash Abiri; Ethan G Muhonen; Frank P K Hsu; Edward C Kuan
Journal:  Am J Rhinol Allergy       Date:  2020-10-29       Impact factor: 2.467

Review 8.  The expanded endonasal approach in pediatric skull base surgery: A review.

Authors:  Nyall R London; Gustavo G Rangel; Patrick C Walz
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-03-04

9.  Intensity-modulated particle beam radiation therapy in the management of olfactory neuroblastoma.

Authors:  Weixu Hu; Jiyi Hu; Jing Gao; Jing Yang; Xianxin Qiu; Lin Kong; Jiade J Lu
Journal:  Ann Transl Med       Date:  2020-08

10.  A novel nomogram to predict the overall survival in esthesinoeroblastoma.

Authors:  Lijie Jiang; Tengjiao Lin; Yu Zhang; Wenxiang Gao; Jie Deng; Zhaofeng Xu; Xin Luo; Zhaoqi Huang; Fenghong Chen; Jianbo Shi; Yinyan Lai
Journal:  BMC Cancer       Date:  2020-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.